# A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors

> **NCT04699929** · PHASE1 · COMPLETED · sponsor: **Eucure (Beijing) Biopharma Co., Ltd** · enrollment: 17 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** YH001

## Key facts

- **NCT ID:** NCT04699929
- **Lead sponsor:** Eucure (Beijing) Biopharma Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-26
- **Primary completion:** 2022-10-08
- **Final completion:** 2022-10-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04699929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04699929, "A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04699929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*